27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.

Analyst Stock Ratings Initiations

Buy NowGet Alert
05/17/2024AVOBuy Now
Mission Produce
$12.8716.55%Lake Street
Ben Klieve48%
 → $15Initiates → BuyGet Alert
05/17/2024IMMPBuy Now
Immutep
$3.00233.33%Capital One
Naureen Quibria21%
 → $10Initiates → OverweightGet Alert
05/17/2024BODIBuy Now
Beachbody Co
$8.4653.66%Canaccord Genuity
Susan Anderson72%
 → $13Initiates → BuyGet Alert
05/17/2024ABBVBuy Now
AbbVie
$166.3520.23%Cantor Fitzgerald
Louise Chen70%
 → $200Initiates → OverweightGet Alert
05/17/2024REEBuy Now
REE Automotive
$5.24167.43%Roth MKM
Craig Irwin40%
 → $14Initiates → BuyGet Alert
05/17/2024CFLTBuy Now
Confluent
$32.2014.91%Oppenheimer
Ittai Kidron71%
 → $37Initiates → OutperformGet Alert
05/17/2024CAPRBuy Now
Capricor Therapeutics
$6.20125.81%Oppenheimer
Leland Gershell70%
 → $14Initiates → OutperformGet Alert
05/16/2024TXNBuy Now
Texas Instruments
$194.93-23.05%Wells Fargo
Gary Mobley73%
 → $150Initiates → UnderweightGet Alert
05/16/2024TCRXBuy Now
TScan Therapeutics
$8.9833.63%BTIG
Justin Zelin60%
 → $12Initiates → BuyGet Alert
05/16/2024VNCEBuy Now
Vince Holding
$1.6581.82%Small Cap Consumer Research
Eric Beder59%
 → $3Initiates → BuyGet Alert
05/16/2024SNBuy Now
SharkNinja
$75.3419.46%B of A Securities
Alexander Perry21%
 → $90Initiates → BuyGet Alert
05/16/2024KWRBuy Now
Quaker Houghton
$194.7112.99%Piper Sandler
Charles Neivert47%
 → $220Initiates → OverweightGet Alert
05/16/2024DNTHBuy Now
Dianthus Therapeutics
$25.6356.07%HC Wainwright & Co.
Swayampakula Ramakanth68%
 → $40Initiates → BuyGet Alert
05/16/2024CNTXBuy Now
Context Therapeutics
$2.01123.88%Piper Sandler
Joseph Catanzaro46%
 → $4.5Initiates → OverweightGet Alert
05/15/2024NAMSBuy Now
NewAmsterdam Pharma
$20.09—TD Cowen
Tyler Van Buren53%
—Initiates → BuyGet Alert
05/15/2024LSPDBuy Now
Lightspeed Commerce
$15.36-8.85%Jefferies
Trevor Williams59%
 → $14Initiates → HoldGet Alert
05/15/2024ITGRBuy Now
Integer Holdings
$120.9213.3%Truist Securities
Richard Newitter73%
 → $137Initiates → BuyGet Alert
05/15/2024WVEBuy Now
WAVE Life Sciences
$6.2675.72%Wells Fargo
Tiago Fauth38%
 → $11Initiates → OverweightGet Alert
05/15/2024GRNTBuy Now
Granite Ridge Resources
$6.4636.22%Roth MKM
John White67%
 → $8.8Initiates → BuyGet Alert

Recent Analyst Stock Rating Initiation News

AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst
Cantor Fitzgerald initiates coverage on AbbVie with an Overweight rating and a $200 price target. AbbVie is set to manage Humira biosimilar erosion, drive growth with Skyrizi, Rinvoq, and emraclidine, and achieve a high single-digit CAGR from 2024 to 2029.
Lake Street Initiates Coverage On Mission Produce with Buy Rating, Announces Price Target of $15
Lake Street analyst Ben Klieve initiates coverage on Mission Produce (NASDAQ:AVO) with a Buy rating and announces Price Target of $15.
REE Automotive: Electrifying The Truck Stop? Analyst Bullish On EV Platform
Analyst initiates Buy rating for REE Automotive with $14 price target. Expects growth catalyst in FY24, revenue ramp in FY25, positive margins in FY26.
Confluent Set to Capture Major Market Share with Unique Streaming Tech: Oppenheimer Analyst
Oppenheimer analyst initiates coverage on Confluent Inc (CFLT) with Outperform rating and price target of $37, citing unique technology, large TAM, and potential for strong growth in real-time data market.
Capital One Initiates Coverage On Immutep with Overweight Rating, Announces Price Target of $10
Capital One analyst Naureen Quibria initiates coverage on Immutep (NASDAQ:IMMP) with a Overweight rating and announces Price Target of $10.
Canaccord Genuity Initiates Coverage On Beachbody Co with Buy Rating, Announces Price Target of $13
Canaccord Genuity analyst Susan Anderson initiates coverage on Beachbody Co (NYSE:BODI) with a Buy rating and announces Price Target of $13.
Cantor Fitzgerald Initiates Coverage On AbbVie with Overweight Rating, Announces Price Target of $200
Cantor Fitzgerald analyst Louise Chen initiates coverage on AbbVie (NYSE:ABBV) with a Overweight rating and announces Price Target of $200.
Roth MKM Initiates Coverage On REE Automotive with Buy Rating, Announces Price Target of $14
Roth MKM analyst Craig Irwin initiates coverage on REE Automotive (NASDAQ:REE) with a Buy rating and announces Price Target of $14.
Oppenheimer Initiates Coverage On Confluent with Outperform Rating, Announces Price Target of $37
Oppenheimer analyst Ittai Kidron initiates coverage on Confluent (NASDAQ:CFLT) with a Outperform rating and announces Price Target of $37.
Oppenheimer Initiates Coverage On Capricor Therapeutics with Outperform Rating, Announces Price Target of $14
Oppenheimer analyst Leland Gershell initiates coverage on Capricor Therapeutics (NASDAQ:CAPR) with a Outperform rating and announces Price Target of $14.
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free

About Luke Jacobi

Luke Jacobi is a distinguished professional known for his role as President at Benzinga, a renowned financial media outlet. With a background in business operations and management, Luke brings valuable expertise to his position, overseeing various aspects of Benzinga’s operations. His contributions play a crucial role in the company’s success, ensuring efficiency and effectiveness across different departments. Prior to his role at Benzinga, Luke has held positions that have honed his skills in leadership and strategic decision-making. With a keen understanding of the financial industry and a commitment to driving innovation, Luke continues to make significant contributions to Benzinga’s mission of providing high-quality financial news and analysis.